Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

NCT04278872 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early as the goal of determining a safe and efficacious dose for further development for the treatment of VMS was not met

Conditions

Interventions

Sponsor

Sojournix, Inc.